Enlightify notifies NYSE of intent to cure price deficiency

Enlightify (ENFY) has notified the New York Stock Exchange that it intends to cure the price deficiency that resulted from the fact that the 30-trading-day average closing price per share of the company’s common stock was below $1.00, which is the minimum average share price required for continued listing under NYSE rules. Under NYSE rules, the company has six months to regain compliance with this continued listing standard and avoid delisting. The company’s common stock continues to be listed and traded on the NYSE, subject to the company’s compliance with other NYSE continued listing requirements. The NYSE notification does not affect the company’s business operations or its Securities and Exchange Commission reporting obligations. The NYSE notification does not conflict with or cause an event of default under any of the company’s material debt arrangements or other agreements.